Casdin Partners Master Fund, L.p. - Net Worth and Insider Trading

Over the past 18 months, Casdin Partners Master Fund, L.p. made 4 insider transaction in BioLife Solutions Inc (BLFS) with a net purchase of 1,135,630. Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 162,277 shares made by Aby J. Mathew , a net sale of 58,182 shares made by Todd Berard , and a net sale of 16,108 shares made by Karen A. Foster .

In summary, during the past 3 months, insiders sold 83,754 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 83,754 shares. During the past 18 months, 511,421 shares of BioLife Solutions Inc (BLFS) were sold and 1,135,630 shares were bought by its insiders, resulting in a net purchase of 624,209 shares.

BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Partners Master Fund, L.p. made no insider transaction in Fulcrum Therapeutics Inc (FULC). Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net purchase of 4,609,704 shares made by Ra Capital Healthcare Fund Lp , a net sale of 5,330 shares made by Greg Tourangeau , and a net purchase of 43,360 shares made by Alex Sapir .

In summary, during the past 3 months, insiders sold 5,120 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 43,360 shares, with a net purchase of 38,240 shares. During the past 18 months, 12,096 shares of Fulcrum Therapeutics Inc (FULC) were sold and 4,653,064 shares were bought by its insiders, resulting in a net purchase of 4,640,968 shares.

Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Partners Master Fund, L.p. made 3 insider transaction in Standard BioTools Inc (LAB) with a net purchase of 2,803,475. Other recent insider transactions involving Standard BioTools Inc (LAB) include a net purchase of 1,200,000 shares made by Eli Casdin , a net purchase of 85,984 shares made by Jeffrey G. Black ,

In summary, during the past 3 months, insiders sold 0 shares of Standard BioTools Inc (LAB) in total and bought 1,603,475 shares, with a net purchase of 1,603,475 shares. During the past 18 months, 0 shares of Standard BioTools Inc (LAB) were sold and 4,089,459 shares were bought by its insiders, resulting in a net purchase of 4,089,459 shares.

Standard BioTools Inc (LAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Partners Master Fund, L.p. made no insider transaction in MaxCyte Inc (MXCT). Other recent insider transactions involving MaxCyte Inc (MXCT) include a net sale of 360,000 shares made by Douglas Doerfler , a net sale of 60,000 shares made by John Joseph Johnston , and a net sale of 145,666 shares made by Thomas M. Ross .

In summary, during the past 3 months, insiders sold 10,000 shares of MaxCyte Inc (MXCT) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 565,666 shares of MaxCyte Inc (MXCT) were sold and 80,000 shares were bought by its insiders, resulting in a net sale of 485,666 shares.

MaxCyte Inc (MXCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Partners Master Fund, L.p. made no insider transaction in Absci Corp (ABSI). Other recent insider transactions involving Absci Corp (ABSI) include a net purchase of 222,222 shares made by Redmile Group, Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Absci Corp (ABSI) in total and bought 222,222 shares, with a net purchase of 222,222 shares. During the past 18 months, 0 shares of Absci Corp (ABSI) were sold and 222,222 shares were bought by its insiders, resulting in a net purchase of 222,222 shares.

Absci Corp (ABSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Partners Master Fund, L.p. made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,108 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net purchase of 76,000 shares made by Andrew D. Ashe .

In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 76,000 shares, with a net purchase of 74,486 shares. During the past 18 months, 3,487 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,872,513 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Partners Master Fund, L.p. made no insider transaction in Tenaya Therapeutics Inc (TNYA). Other recent insider transactions involving Tenaya Therapeutics Inc (TNYA) include a net purchase of 3,983,891 shares made by Column Group Iii Gp, Lp , a net purchase of 3,983,891 shares made by David V Goeddel , and a net sale of 25,800 shares made by Timothy Hoey .

In summary, during the past 3 months, insiders sold 3,300 shares of Tenaya Therapeutics Inc (TNYA) in total and bought 0 shares, with a net sale of 3,300 shares. During the past 18 months, 59,437 shares of Tenaya Therapeutics Inc (TNYA) were sold and 7,967,782 shares were bought by its insiders, resulting in a net purchase of 7,908,345 shares.

Tenaya Therapeutics Inc (TNYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Casdin Partners Master Fund, L.p. made no insider transaction in GeneDx Holdings Corp (WGS). Other recent insider transactions involving GeneDx Holdings Corp (WGS) include a net sale of 62,666 shares made by Kareem Saad , a net sale of 69,493 shares made by Kevin Feeley , and a net purchase of 30,554 shares made by Katherine Stueland .

In summary, during the past 3 months, insiders sold 25,695 shares of GeneDx Holdings Corp (WGS) in total and bought 90,900 shares, with a net purchase of 65,205 shares. During the past 18 months, 1,192,040 shares of GeneDx Holdings Corp (WGS) were sold and 1,529,954 shares were bought by its insiders, resulting in a net purchase of 337,914 shares.

GeneDx Holdings Corp (WGS)'s detailed insider trading history can be found in Insider Trading Tracker table.